Free Trial

Satellos Bioscience (MSLE) Earnings Date, Estimates & Call Transcripts

$6.44 -0.51 (-7.34%)
As of 12:34 PM Eastern

Satellos Bioscience Earnings Summary

Satellos Bioscience announced Q1 2026 earnings on May 15, 2026, reporting an EPS of -$0.53, which missed analysts' consensus estimates of -$0.51 by $0.02. With a trailing EPS of -$1.60, Satellos Bioscience's earnings are expected to decrease next year, from ($2.26) to ($2.68) per share.

Consensus EPS
(May. 15)
-$0.51
Actual EPS
(May. 15)
-$0.53 Missed By -$0.02
Get Satellos Bioscience Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Satellos Bioscience and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

MSLE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Satellos Bioscience Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20261-$0.36-$0.36-$0.36
Q3 20261-$0.36-$0.36-$0.36
Q4 20261-$0.36-$0.36-$0.36
2026 3 -$1.08 -$1.08 -$1.08
Q1 20271-$0.39-$0.39-$0.39
Q2 20271-$0.42-$0.42-$0.42
Q3 20271-$0.46-$0.46-$0.46
Q4 20271-$0.49-$0.49-$0.49

Satellos Bioscience Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026-$0.51-$0.53 -$0.02-$0.53--
3/27/2026Q4 2025-$0.36-$0.47 -$0.11-$0.47--

Data powered by Fiscal.ai.

Satellos Bioscience Earnings - Frequently Asked Questions

Satellos Bioscience (NASDAQ:MSLE) last announced its quarterly earning data on Friday, May 15, 2026. Learn more on MSLE's earnings history.

In the previous quarter, Satellos Bioscience (NASDAQ:MSLE) missed the analysts' consensus estimate of ($0.51) by $0.02 with a reported earnings per share (EPS) of ($0.53). Learn more on analysts' earnings estimate vs. MSLE's actual earnings.

Satellos Bioscience (NASDAQ:MSLE) has a recorded net income of -$24.87 million. MSLE has generated -$1.60 earnings per share over the last four quarters.

Satellos Bioscience's earnings are expected to decrease from ($2.26) per share to ($2.68) per share in the next year.


This page (NASDAQ:MSLE) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners